Cheng Liu

2.2k total citations
82 papers, 1.5k citations indexed

About

Cheng Liu is a scholar working on Oncology, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Cheng Liu has authored 82 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Oncology, 27 papers in Pathology and Forensic Medicine and 23 papers in Molecular Biology. Recurrent topics in Cheng Liu's work include Genetic factors in colorectal cancer (16 papers), Colorectal Cancer Screening and Detection (10 papers) and Colorectal Cancer Treatments and Studies (7 papers). Cheng Liu is often cited by papers focused on Genetic factors in colorectal cancer (16 papers), Colorectal Cancer Screening and Detection (10 papers) and Colorectal Cancer Treatments and Studies (7 papers). Cheng Liu collaborates with scholars based in China, Australia and United States. Cheng Liu's co-authors include Vicki Whitehall, Mark Bettington, Barbara Leggett, Ping Liu, Neal I. Walker, Chenghai Liu, Yiyang Hu, Dawei Xu, Magnus Björkholm and Zhifang Liu and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and PLoS ONE.

In The Last Decade

Cheng Liu

79 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cheng Liu China 21 601 536 246 242 234 82 1.5k
Huanyu Zhao China 18 429 0.7× 585 1.1× 141 0.6× 240 1.0× 333 1.4× 69 1.3k
Cristian Loretelli Italy 20 382 0.6× 570 1.1× 223 0.9× 413 1.7× 196 0.8× 65 1.4k
Feng Tian China 20 371 0.6× 434 0.8× 107 0.4× 243 1.0× 185 0.8× 104 1.6k
Shu Cao United States 23 502 0.8× 478 0.9× 153 0.6× 237 1.0× 209 0.9× 114 1.5k
Luigi Rossi Italy 20 342 0.6× 400 0.7× 180 0.7× 219 0.9× 332 1.4× 58 1.5k
Qiliu Peng China 22 308 0.5× 492 0.9× 193 0.8× 260 1.1× 119 0.5× 80 1.5k
Francesca Ragusa Italy 26 489 0.8× 520 1.0× 372 1.5× 175 0.7× 234 1.0× 71 2.4k
Tatsunori Miyata Japan 20 626 1.0× 315 0.6× 219 0.9× 215 0.9× 280 1.2× 91 1.5k
Leah H. Biller United States 11 851 1.4× 728 1.4× 277 1.1× 510 2.1× 363 1.6× 17 2.1k
Vincenzo Formica Italy 24 1.1k 1.8× 317 0.6× 179 0.7× 293 1.2× 356 1.5× 115 1.8k

Countries citing papers authored by Cheng Liu

Since Specialization
Citations

This map shows the geographic impact of Cheng Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheng Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheng Liu more than expected).

Fields of papers citing papers by Cheng Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheng Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheng Liu. The network helps show where Cheng Liu may publish in the future.

Co-authorship network of co-authors of Cheng Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Cheng Liu. A scholar is included among the top collaborators of Cheng Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheng Liu. Cheng Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ménard, Marie, Lilit Grigoryan, Jasmine Lee, et al.. (2025). Abstract PR012: The RAS(ON) G12D-selective inhibitor RMC-9805 synergizes with anti-PD-1 to extend durability of antitumor activity in KRAS G12D-driven preclinical cancer models. Cancer Immunology Research. 13(2_Supplement). PR012–PR012. 1 indexed citations
2.
Hu, Jintao, Juanyi Shi, Shizhong Xu, et al.. (2025). A novel polypeptide encoded by circSPIRE1 promotes prostate cancer proliferation and migration by restraining the ubiquitin-dependent degradation of LRP5. Journal of Experimental & Clinical Cancer Research. 44(1). 218–218. 1 indexed citations
3.
4.
Hu, Jintao, et al.. (2024). Integrative analysis regarding the correlation between collagen-related genes and prostate cancer. BMC Cancer. 24(1). 1038–1038. 1 indexed citations
5.
6.
Wu, Yaqian, Qiming Zhang, Xiaojun Tian, et al.. (2023). Causal inference between rheumatoid arthritis and prostate cancer. Clinical and Experimental Medicine. 23(8). 4681–4694. 6 indexed citations
7.
Suraweera, Amila, Mark N. Adams, Pascal H. G. Duijf, et al.. (2021). Correction: Defining COMMD4 as an anti-cancer therapeutic target and prognostic factor in non-small cell lung cancer. British Journal of Cancer. 124(9). 1612–1612. 16 indexed citations
8.
Liu, Cheng, Yongping Zhang, Huiyu Yuan, et al.. (2021). 18F-FLT PET/CT imaging for early monitoring response to CDK4/6 inhibitor therapy in triple negative breast cancer. Annals of Nuclear Medicine. 35(5). 600–607. 12 indexed citations
9.
Liu, Cheng, Diane McKeone, Catherine Bond, et al.. (2021). Aspirin reduces the incidence of metastasis in a pre-clinical study of Braf mutant serrated colorectal neoplasia. British Journal of Cancer. 124(11). 1820–1827. 6 indexed citations
10.
Liu, Cheng, et al.. (2019). Identification and resolution of drug-related problems in a tertiary hospital respiratory unit in China. International Journal of Clinical Pharmacy. 41(6). 1570–1577. 17 indexed citations
11.
Mittal, Deepak, Ailin Lepletier, Jason Madore, et al.. (2019). CD96 Is an Immune Checkpoint That Regulates CD8+ T-cell Antitumor Function. Cancer Immunology Research. 7(4). 559–571. 90 indexed citations
12.
Yuan, Zeting, Yanyan Qiu, Tingting Jia, et al.. (2017). Reversal of P-gp-mediated multidrug resistance in colon cancer by cinobufagin. Oncology Reports. 37(3). 1815–1825. 54 indexed citations
13.
14.
Li, Nan, Xuejuan Wang, Hua Zhu, et al.. (2016). Clinical Evaluation of 99mTc-Rituximab for Sentinel Lymph Node Mapping in Breast Cancer Patients. Journal of Nuclear Medicine. 57(8). 1214–1220. 16 indexed citations
15.
Liu, Cheng, Zhuohang Li, Liangkuan Bi, et al.. (2014). NOTCH1 signaling promotes chemoresistance via regulating ABCC1 expression in prostate cancer stem cells. Molecular and Cellular Biochemistry. 393(1-2). 265–270. 49 indexed citations
16.
Xia, Xiaoping, Wei Chen, Jiaoyuan Li, et al.. (2014). Body Mass Index and Risk of Breast Cancer: A Nonlinear Dose-Response Meta-Analysis of Prospective Studies. Scientific Reports. 4(1). 7480–7480. 69 indexed citations
17.
Yan, Keqiang, et al.. (2012). Renal cell carcinoma presenting as exfoliative dermatitis (erythroderma) a case report. Clinical Nephrology. 80(7). 63–66. 3 indexed citations
18.
Liu, Cheng, et al.. (2011). The value of MDCT in diagnosis of hyaline-vascular Castleman's disease. European Journal of Radiology. 81(9). 2436–2439. 1 indexed citations
19.
Pryer, Nancy, Victoria Sung, Ursula Jeffry, et al.. (2009). Abstract #DDT02-2: MCS110: a monoclonal antibody with potent neutralizing activity against macrophage colony-stimulating factor for the treatment of tumor-induced osteolysis. Cancer Research. 69. 1 indexed citations
20.
Luo, Yunping, He Zhou, Joerg Krueger, et al.. (2006). Targeting tumor-associated macrophages: A novel strategy against breast cancer.. Cancer Research. 66. 1307–1307. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Huanyu Zhao Breakdown of academic impact, for papers by Cristian Loretelli Breakdown of academic impact, for papers by Feng Tian Breakdown of academic impact, for papers by Shu Cao Breakdown of academic impact, for papers by Luigi Rossi Breakdown of academic impact, for papers by Qiliu Peng Breakdown of academic impact, for papers by Francesca Ragusa Breakdown of academic impact, for papers by Tatsunori Miyata Breakdown of academic impact, for papers by Leah H. Biller Breakdown of academic impact, for papers by Vincenzo Formica
Rankless by CCL
2026